Education
About Us
Working with TipRanks
Follow Us
Zimmer Biomet Holdings (GB:0QQD)
:0QQD
RESEARCH TOOLSreports
0QQD Analyst Ratings
Hold
5 Buy
11 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0QQD Stock 12 Month Forecast
Average Price Target
CHF100.28
▼(-12.04% Downside)
| Highest Price TargetCHF116.03 | Average Price TargetCHF100.28 | Lowest Price TargetCHF88.68 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Canaccord Genuity
Reiterated
04/21/25
RBC Capital
Reiterated
04/15/25
BTIG
Reiterated
04/14/25
Bank of America Securities
Reiterated
03/24/25
Truist Financial
Reiterated
03/13/25
TD Cowen
Reiterated
03/12/25
Morgan Stanley
Reiterated
03/12/25
Wells Fargo
Reiterated
03/07/25
Citi
Reiterated
02/14/25
Barclays
Reiterated
02/10/25
Raymond James
CHF98.54
Buy
-13.56%
Downside
Reiterated
02/07/25
Analysts Are Bullish on Top Healthcare Stocks: Zimmer Biomet Holdings (ZBH), Kura Oncology (KURA)
Robert W. Baird
CHF114.28→CHF107.65
Buy
-5.57%
Downside
Reiterated
02/07/25
Zimmer Biomet price target lowered to $130 from $138 at BairdZimmer Biomet price target lowered to $130 from $138 at Baird
Deutsche Bank
CHF95.23→CHF88.6
Hold
-22.28%
Downside
Reiterated
02/07/25
Zimmer Biomet price target lowered to $107 from $115 at Deutsche BankZimmer Biomet price target lowered to $107 from $115 at Deutsche Bank
Roth MKM
CHF106.82
Hold
-6.30%
Downside
Reiterated
02/07/25
Roth MKM Sticks to Its Hold Rating for Zimmer Biomet Holdings (ZBH)
JMP Securities
CHF115.93
Buy
1.69%
Upside
Reiterated
02/07/25
Analysts Are Bullish on Top Healthcare Stocks: Globus Medical (GMED), Zimmer Biomet Holdings (ZBH)
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Canaccord Genuity
Reiterated
04/21/25
RBC Capital
Reiterated
04/15/25
BTIG
Reiterated
04/14/25
Bank of America Securities
Reiterated
03/24/25
Truist Financial
Reiterated
03/13/25
TD Cowen
Reiterated
03/12/25
Morgan Stanley
Reiterated
03/12/25
Wells Fargo
Reiterated
03/07/25
Citi
Reiterated
02/14/25
Barclays
Reiterated
02/10/25
Raymond James
CHF98.54
Buy
-13.56%
Downside
Reiterated
02/07/25
Analysts Are Bullish on Top Healthcare Stocks: Zimmer Biomet Holdings (ZBH), Kura Oncology (KURA)
Robert W. Baird
CHF114.28→CHF107.65
Buy
-5.57%
Downside
Reiterated
02/07/25
Zimmer Biomet price target lowered to $130 from $138 at BairdZimmer Biomet price target lowered to $130 from $138 at Baird
Deutsche Bank
CHF95.23→CHF88.6
Hold
-22.28%
Downside
Reiterated
02/07/25
Zimmer Biomet price target lowered to $107 from $115 at Deutsche BankZimmer Biomet price target lowered to $107 from $115 at Deutsche Bank
Roth MKM
CHF106.82
Hold
-6.30%
Downside
Reiterated
02/07/25
Roth MKM Sticks to Its Hold Rating for Zimmer Biomet Holdings (ZBH)
JMP Securities
CHF115.93
Buy
1.69%
Upside
Reiterated
02/07/25
Analysts Are Bullish on Top Healthcare Stocks: Globus Medical (GMED), Zimmer Biomet Holdings (ZBH)
Best Analysts Covering Zimmer Biomet Holdings
Which Analyst Should I Follow If I Want to Buy GB:0QQD and Sell After:
1 Month
xxx
Success Rate
11/19 ratings generated profit
Average Return
+0.07%
reiterated a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.89% of your transactions generating a profit, with an average return of +0.07% per trade.
3 Months
xxx
Success Rate
27/45 ratings generated profit
Average Return
+2.37%
assigned a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +2.37% per trade.
1 Year
Success Rate
29/45 ratings generated profit
Average Return
+4.93%
assigned a buy rating 6 months ago
Copying Steven Lichtman's trades and holding each position for 1 Year would result in 64.44% of your transactions generating a profit, with an average return of +4.93% per trade.
2 Years
xxx
Success Rate
25/45 ratings generated profit
Average Return
+5.41%
assigned a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 55.56% of your transactions generating a profit, with an average return of +5.41% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0QQD Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
0
0
0
0
0
Buy
13
6
11
9
8
Hold
14
21
26
26
14
Sell
1
2
3
2
1
Strong Sell
0
0
0
0
0
total
28
29
40
37
23
Each month's total comprises the sum of three months' worth of ratings.
0QQD Financial Forecast
0QQD Stock Forecast FAQ
What is GB:0QQD’s average 12-month price target, according to analysts?
Based on analyst ratings, Zimmer Biomet Holdings’s 12-month average price target is 100.28.
What is GB:0QQD’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GB:0QQD, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Zimmer Biomet Holdings a Buy, Sell or Hold?
Zimmer Biomet Holdings has a consensus rating of Hold, which is based on 5 buy ratings, 11 hold ratings and 1 sell ratings.
What is Zimmer Biomet Holdings’s share price target?
The average share price target for Zimmer Biomet Holdings is 100.28. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF116.03 ,and the lowest forecast is CHF88.68. The average share price target represents -12.04% Decrease from the current price of CHF114.
The highest analyst share price target is CHF116.03 ,and the lowest forecast is CHF88.68. The average share price target represents -12.04% Decrease from the current price of CHF114.
What do analysts say about Zimmer Biomet Holdings?
Zimmer Biomet Holdings’s analyst rating consensus is a Hold. This is based on the ratings of 17 Wall Streets Analysts.
How can I buy shares of Zimmer Biomet Holdings?
To buy shares of GB:0QQD, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.